Influence of non-cardiac comorbidities on outcome after percutaneous mitral valve repair: results from the German transcatheter mitral valve interventions (TRAMI) registry
Conclusions
MitraClip device placement is feasible and safe in patients with multiple non-cardiac comorbidities resulting in a significant clinical improvement and acceptable intrahospital and 30-day event rates. Renal failure is an independent predictor of outcome.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Cancer & Oncology | Cardiology | Diabetes | Endocrinology | Gastroschisis Repair | Heart | Heart Attack | Neurology | Palliative | Palliative Care | Renal Failure | Stroke